Home › Funds › Q Global Advisors, LLC › ASND

Q Global Advisors, LLC position in ASND

ASCENDIS PHARMA A/S · Health Care

Q Global Advisors, LLC reported holding 41,000 shares of ASND (ASCENDIS PHARMA A/S) in its Q3 2026 13F filing — a position valued at US$396K, representing 0.28% of its reported portfolio and ranking #15 among its reported holdings. Q Global Advisors, LLC has disclosed ASND holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)41.00K sh
Reported value held$396.00K
Portfolio Weight0.28%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Q Global Advisors, LLC's ASND position evolved

Q Global Advisors, LLC first disclosed a stake in ASND in Q3 2023 at 285,000 shares (US$26.7M). The position peaked in Q2 2025 at 255,000 shares, worth US$44.0M. Across 13 filings, Q Global Advisors, LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 41,000 shares valued at US$396K. Notable position changes include a 33% trim in Q3 2025 (shares rose 7% over the following quarter), a 78% trim in Q1 2026 (shares rose 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 285.00K $26.69M New
Q4 2023 285.00K $35.90M Hold
Q1 2024 285.00K $43.08M Hold
Q2 2024 219.46K $29.93M Reduce
Q3 2024 219.46K $32.77M Hold
Q4 2024 219.46K $30.21M Hold
Q1 2025 248.89K $38.79M Add
Q2 2025 255.00K $44.01M Add
Q3 2025 170.00K $33.80M Reduce
Q4 2025 190.00K $40.52M Add
Q1 2026 41.00K $9.38M Reduce
Q2 2026 41.00K $9.38M Hold
Q3 2026 41.00K $396.00K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ASND and 13F data

ASND (ASCENDIS PHARMA A/S) is a Health Care company. 37 other funds we track also report a position in ASND — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$2.74B), T. Rowe Price Investment Management, Inc. (US$1.80B), Avoro Capital Advisors LLC (US$1.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ASND

All ASND fund holders →

FAQ

How long has Q Global Advisors, LLC held ASND?

Q Global Advisors, LLC has disclosed ASND holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Q Global Advisors, LLC's current position in ASND?

As of Q3 2026, Q Global Advisors, LLC holds 41.00K shares of ASND (ASCENDIS PHARMA A/S), valued at $396.00K, representing 0.28% of its reported portfolio and ranking #15.

Has Q Global Advisors, LLC been buying or selling ASND?

In the latest 13F filing (Q3 2026), Q Global Advisors, LLC held unchanged its position in ASND. The position peaked in Q2 2025 at 255.00K shares.

Which other funds hold ASND?

Other major institutional holders of ASND include RA CAPITAL MANAGEMENT, L.P., T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.